Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|136|12|2967-2972

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.12, 2015-06, pp. : 2967-2972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Kidney Disease Management: Comparison between Renal Transplant Recipients and Nontransplant Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 107, Iss. 1, 2007-07 ,pp. : c7-c13

Karger

Access to resources Recommend Favorite

Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 404-412

John Wiley & Sons Inc

Access to resources Recommend Favorite

De novo Urothelial Carcinoma in Kidney Transplantation Patients with End-Stage Aristolochic Acid Nephropathy in China

By  

Urologia Internationalis, Vol. 83, Iss. 2, 2009-09 ,pp. : 200-205

Karger

Access to resources Recommend Favorite

Renal function and incidence of chronic kidney disease in HIV patients: A Danish cohort study

By Rasch Magnus G.   Engsig Frederik N.   Feldt-Rasmussen Bo   Kirk Ole   Kronborg Gitte   Pedersen Court   Gerstoft Jan   Obel Niels  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 9, 2012-09 ,pp. : 689-696

Informa Healthcare

Access to resources Recommend Favorite

Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease

By Dean Bonnie B.   Dylan Michelle   Gano Anacleto   Knight Kevin   Ofman Joshua J.   Levine Barton S.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 981-988

Informa Healthcare

Access to resources Recommend Favorite